Drug makers to face more business suspension

Pharmaceutical companies, which are found to violate the current regulations, will be subject to more halts of business operation instead of financial penalty from the middle of this month, according to the Korea Food and Drug Administration.

So far, many companies have opted for paying the fines of up to 50 million won.

However, pharmaceutical companies are opposed to the plan, with some...